What are the dosage recommendations for amoxicillin (amoxicillin-clavulanate) in patients with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate Dosing in Renal Failure

Amoxicillin-clavulanate requires dose adjustment in patients with severe renal impairment (GFR <30 mL/min), with the standard recommendation being to avoid the 875 mg tablet formulation and instead use lower doses with extended intervals to prevent amoxicillin accumulation while maintaining adequate clavulanate levels. 1

Key Dosing Principles

The critical issue with amoxicillin-clavulanate in renal failure is that amoxicillin accumulates more significantly than clavulanate as kidney function declines, creating a widening ratio between the two components that can lead to amoxicillin toxicity if standard doses are maintained. 2

Renal Function-Based Adjustments

  • For GFR <30 mL/min (severe renal impairment): Dosage adjustment is required because amoxicillin is primarily eliminated by the kidney, and the risk of adverse reactions increases substantially in patients with impaired renal function. 1

  • The pharmacokinetic data demonstrates that as GFR decreases, total body clearance of amoxicillin drops more dramatically than clavulanate clearance, resulting in disproportionate accumulation. 2

  • Specific dosing recommendations for severe renal impairment (GFR <30 mL/min):

    • Avoid the 875 mg/125 mg formulation entirely 1
    • Use reduced doses with extended dosing intervals 1, 3
    • The serum half-life of amoxicillin increases from approximately 71 minutes in normal renal function to 16 hours in anephric patients 3

Hemodialysis Considerations

  • For patients on hemodialysis: Amoxicillin is cleared during dialysis with a half-life of approximately 2.3-3.6 hours during the procedure. 4, 3

  • Administer the dose after hemodialysis to avoid premature drug removal and ensure adequate therapeutic levels. 4

  • A supplementary dose may be needed post-dialysis since hemodialysis effectively removes amoxicillin due to its low molecular weight and reduced protein binding. 5

Elderly Patients

  • Greater caution is warranted in elderly patients because they are more likely to have decreased renal function, even if not formally diagnosed with renal impairment. 1

  • Monitor renal function and select doses carefully in this population to prevent accumulation-related toxicity. 1

Clinical Monitoring

  • Assess baseline renal function using creatinine clearance or GFR before initiating therapy. 3, 2

  • The correlation between amoxicillin half-life and creatinine clearance is highly significant (r = 0.967), allowing for precise dosage adjustments based on measured renal function. 3

  • Monitor for dose-related toxicity, particularly neurological symptoms, as amoxicillin can accumulate to toxic levels in severe renal impairment. 6

Important Caveats

  • The fixed-ratio combination becomes problematic in renal failure because the area under the curve (AUC) ratio of amoxicillin to clavulanate increases dramatically—from approximately 4.9:1 in normal renal function to 14.7:1 in hemodialysis patients. 2

  • Absorption is also affected: Patients with renal impairment show a significant increase in the absorption half-life of amoxicillin, which further complicates dosing. 4

  • Do not use standard dosing tables without adjustment—a 30% dose reduction is recommended for each level of renal impairment (moderate and severe). 5

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.